Edition:
United States

STAAR Surgical Co (STAA.OQ)

STAA.OQ on NASDAQ Stock Exchange Global Market

16.02USD
12:23pm EST
Change (% chg)

$0.03 (+0.16%)
Prev Close
$16.00
Open
$16.00
Day's High
$16.10
Day's Low
$15.90
Volume
28,784
Avg. Vol
36,498
52-wk High
$17.60
52-wk Low
$8.95

Latest Key Developments (Source: Significant Developments)

Staar Surgical reports Q3 earnings per share $0.03
Wednesday, 8 Nov 2017 04:01pm EST 

Nov 8 (Reuters) - Staar Surgical Co ::Staar Surgical reports third quarter 2017 results.Q3 adjusted earnings per share $0.04.Q3 earnings per share $0.03.Q3 sales $23.5 million versus I/B/E/S view $21.5 million.Q3 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S.Staar Surgical Co - ‍cash, cash equivalents and restricted cash at September 29, 2017 totaled $16.3 million, compared to $14.1 million at end of Q4 of 2016​.  Full Article

Staar Surgical names Deborah Andrews as CFO
Thursday, 28 Sep 2017 10:20am EDT 

Sept 28 (Reuters) - Staar Surgical Co ::Staar Surgical names Deborah Andrews as CFO.Deborah Andrews, interim CFO, has agreed to resume her role as Chief Financial Officer for company​.  Full Article

STAAR Surgical, Seoul/Busan BalGeunSeSang eye clinic announce strategic cooperation agreement
Tuesday, 15 Aug 2017 07:00am EDT 

Aug 15 (Reuters) - STAAR Surgical Co ::STAAR Surgical and Seoul/Busan Balgeunsesang eye clinic announce strategic cooperation agreement.STAAR Surgical Co - ‍agreement to provide STAAR's evo intraocular lenses​.  Full Article

Staar Surgical Q2 loss per share $0.02
Wednesday, 2 Aug 2017 04:01pm EDT 

Aug 2 (Reuters) - Staar Surgical Co :Staar Surgical reports second quarter 2017 results.Q2 adjusted loss per share $0.01.Q2 loss per share $0.02.Q2 sales $21.9 million versus I/B/E/S view $21.7 million.Q2 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.  Full Article

Staar Surgical files for potential mixed shelf offering
Thursday, 11 May 2017 04:28pm EDT 

May 11 (Reuters) - Staar Surgical Co :Staar Surgical Co <<>> files for potential mixed shelf offering of up to $200 million - SEC filing.Staar Surgical says filed the universal shelf registration statement on form S-3 as the co's existing shelf registration expires on May 12, 2017.Staar Surgical says it may make securities offerings under existing shelf registration statement until new registration statement is declared effective.Staar Surgical says there are no plans to offer securities under either shelf registration statement at this time.  Full Article

Staar Surgical reports Q1 sales $20.4 million
Wednesday, 3 May 2017 04:01pm EDT 

May 3 (Reuters) - Staar Surgical Co :Staar Surgical reports first quarter 2017 results.Q1 adjusted loss per share $0.04.Q1 loss per share $0.05.Q1 sales $20.4 million versus I/B/E/S view $20.7 million.Q1 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S.Staar Surgical Co- Cash, cash equivalents and restricted cash at March 31, 2017 totaled $13.6 million, compared to $14.1 million at end of Q4 of 2016.  Full Article

Staar Surgical names Deborah Andrews interim CFO
Wednesday, 5 Apr 2017 07:00am EDT 

Staar Surgical Co - : Staar Surgical names Deborah Andrews interim CFO .Steve Brown has resigned his position as chief financial officer effective April 28, 2017.  Full Article

Stephen Brown notifies intention to resign as chief financial officer of STAAR Surgical
Tuesday, 4 Apr 2017 04:40pm EDT 

STAAR Surgical Co - : Stephen Brown notified co of his intention to resign as vice president and chief financial officer . Says CFO Brown's resignation will become effective on April 28, 2017 .Staar Surgical Co says appointed Deborah Andrews to serve as interim vice president and CFO of company.  Full Article

Staar Surgical Q4 adjusted earnings per share $0.02
Thursday, 2 Mar 2017 04:01pm EST 

Staar Surgical Co : Staar Surgical reports fourth quarter 2016 results . Q4 adjusted earnings per share $0.02 . Staar Surgical Co - on-going FDA remediation effort finished quarter on-track and on-budget . Q4 sales $22.1 million versus I/B/E/S view $22.1 million . Q4 earnings per share view $-0.02 -- Thomson Reuters I/B/E/S .Staar Surgical Co - "first-in-man clinical trial for next generation ICL with EDOF continued in Q4 and results continue to be positive".  Full Article

STAAR Surgical reports Q3 loss per share of $0.04
Thursday, 3 Nov 2016 04:01pm EDT 

Staar Surgical Co : STAAR Surgical co says Q3 worldwide ICL sales and units up 15% from prior year quarter . STAAR Surgical co says Q3 worldwide iol sales up 6% and units down 3% from prior year quarter . Staar surgical reports third quarter 2016 results . Q3 adjusted loss per share $0.02 . Q3 loss per share $0.04 . Q3 sales $20.1 million versus I/B/E/S view $20.7 million .Q3 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Staar Surgical reports Q3 earnings per share $0.03

* Q3 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S